نتایج جستجو برای: inhibition proliferation

تعداد نتایج: 481256  

1998
Catherine M. Verfaillie

Chronic myelogenous leukemia (CML) is characterized by the continuous proliferation and abnormal circulation of malignant hematopoietic progenitors. This may be related to the unresponsiveness of CML progenitors to b1 integrin adhesion receptor-mediated inhibition of progenitor proliferation by the marrow microenvironment. In hematopoietic cell lines, the BCR-ABL oncogene product, p210BCR-ABL, ...

2015
Tanuja Rajah Sek Chuen Chow

The cathepsin B inhibitor, benzyloxycarbonyl-phenylalanine-alanine-fluoromethyl ketone (z-FA-FMK) readily inhibits anti-CD3-induced human T cell proliferation, whereas the analogue benzyloxycarbonyl-phenylalanine-alanine-diazomethyl ketone (z-FA-DMK) had no effect. In contrast, benzyloxycarbonyl-phenylalanine-alanine-chloromethyl ketone (z-FA-CMK) was toxic. The inhibition of T cell proliferati...

Journal: :Oncology reports 2007
Fabian Fehlauer Martina Muench Eckhard Richter Dirk Rades

The aim of this study was to investigate the effect of temozolomide (TZM) in combination with X-rays on proliferation and migration in human glioma spheroids. Multicellular spheroids were derived from GaMg and U87 cell lines. Spheroids were treated with various concentrations of TZM (5 micromol, 0.025 mmol, 0.05 mmol) and irradiation (RT). Proliferation and migration assays were performed. For ...

Journal: :Blood 1998
R Bhatia C M Verfaillie

Chronic myelogenous leukemia (CML) is characterized by the continuous proliferation and abnormal circulation of malignant hematopoietic progenitors. This may be related to the unresponsiveness of CML progenitors to beta1 integrin adhesion receptor-mediated inhibition of progenitor proliferation by the marrow microenvironment. In hematopoietic cell lines, the BCR-ABL oncogene product, p210(BCR-A...

Journal: :Journal of Enzyme Inhibition and Medicinal Chemistry 2021

We report herein anti-proliferation effects of 4-arylthiosemicarbazides, with a cyclopentane substitution at N1 position, on highly virulent RH strain Toxoplasma gondii. Among them, the highest in vitro anti-Toxoplasma activity was found meta-iodo derivative. Further experiments demonstrated inhibitory thiosemicarbazides tyrosinase (Tyr) activity, and good correlation between percentage Tyr inh...

Journal: :Carcinogenesis 2007
Hye Jin You Monique W Bruinsma Tam How Julie H Ostrander Gerard C Blobe

Transforming growth factor beta (TGFbeta) has an important role as a negative regulator of cellular proliferation. The type III transforming growth factor beta receptor (TbetaRIII) has an emerging role as both a TGFbeta superfamily co-receptor and in mediating signaling through its cytoplasmic domain. In L6 myoblasts, TbetaRIII expression enhanced TGFbeta1-mediated growth inhibition, with this ...

Abbas Zare Mirakabadi, Ali Nouri Hasan Morovvati Mohsen Lotfi, Zahra Shahramyar

Our previous studies revealed an inhibitory effect of ICD-85 (Venom derived peptides) on breast cancer cell line MDA-MB231. ICD-85 was also confirmed by in-vivo studies to suppress the breast tumor in mice. However, the exact mechanism of ICD-85 was unknown. Hence, the present study was undertaken to assess the mechanism of ICD-85 effect as an anti-proliferative agent of cancer cells. The effec...

Journal: :The Journal of clinical investigation 2014
Niuscha Yaktapour Frank Meiss Justin Mastroianni Thorsten Zenz Hana Andrlova Nimitha R Mathew Rainer Claus Barbara Hutter Stefan Fröhling Benedikt Brors Dietmar Pfeifer Milena Pantic Ingrid Bartsch Timo S Spehl Philipp T Meyer Justus Duyster Katja Zirlik Tilman Brummer Robert Zeiser

Patients with BRAFV600E/K-driven melanoma respond to the BRAF inhibitor vemurafenib due to subsequent deactivation of the proliferative RAS/RAF/MEK/ERK pathway. In BRAF WT cells and those with mutations that activate or result in high levels of the BRAF activator RAS, BRAF inhibition can lead to ERK activation, resulting in tumorigenic transformation. We describe a patient with malignant melano...

Journal: :International immunopharmacology 2003
Christina Akesson Hanna Lindgren Ronald W Pero Tomas Leanderson Fredrik Ivars

Previous reports have demonstrated that extracts of the plant Uncaria tomentosa inhibit tumor cell proliferation and inflammatory responses. We have confirmed that C-Med 100, a hot water extract of this plant, inhibits tumor cell proliferation albeit with variable efficiency. We extend these findings by showing that this extract also inhibits proliferation of normal mouse T and B lymphocytes an...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید